Finnadvance is a Finnish biotechnology company that develops advanced organ-on-chip platforms for pharmaceutical research. Their biomimetic technology replicates human biological barriers, such as the blood-brain barrier and lung tissue, enabling more accurate drug testing and reducing reliance on animal models. The company focuses on improving preclinical drug development efficiency and success rates.